1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. TREVENA INC
Trevena Inc XNAS: TRVN

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Trevena Inc is on 22 Jul 2025 for the purpose of Trevena Inc First Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Trevena Inc

The latest disclosure was made by Carrie L. Bourdow in Trevena Inc where a trade of 285 Common Stock done at an average price of $1.5 was reported to US exchanges on Oct. 8, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Carrie L. Bourdow Director, Acting CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 285 25,234 (0%) 0% 1.5 419 Common Stock
Carrie L. Bourdow Director, Acting CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 1,055 23,894 (0%) 0% 1.5 1,551 Common Stock
Carrie L. Bourdow Director, Acting CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 285 24,949 (0%) 0% 1.5 419 Common Stock
Carrie L. Bourdow Director, Acting CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. 08 Oct 2024 54 25,662 (0%) 0% 1.5 79 Common Stock
Carrie L. Bourdow Director, Acting CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 143 25,519 (0%) 0% 1.5 210 Common Stock
Mark A. Demitrack Acting CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 144 11,895 (0%) 0% 1.5 212 Common Stock
Mark A. Demitrack Acting CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 45 12,183 (0%) 0% 1.5 66 Common Stock
Mark A. Demitrack Acting CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. 08 Oct 2024 20 12,228 (0%) 0% 1.5 29 Common Stock
Mark A. Demitrack Acting CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 532 11,363 (0%) 0% 1.5 782 Common Stock
Mark A. Demitrack Acting CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 144 12,039 (0%) 0% 1.5 212 Common Stock
Barry Shin Acting COO and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 130 12,031 (0%) 0% 1.5 191 Common Stock
Barry Shin Acting COO and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 17 12,332 (0%) 0% 1.5 25 Common Stock
Barry Shin Acting COO and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.46 per share. 08 Oct 2024 41 12,291 (0%) 0% 1.5 60 Common Stock
Barry Shin Acting COO and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 130 12,161 (0%) 0% 1.5 191 Common Stock
Barry Shin Acting COO and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. 08 Oct 2024 488 11,543 (0%) 0% 1.5 717 Common Stock
Robert T. Yoder SVP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.95 per share. 14 Sep 2024 487 5,868 (0%) 0% 6.0 2,898 Common Stock
Barry Shin SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.00 per share. 14 Sep 2024 3 12,349 (0%) 0% 6 18 Common Stock
Mark H.N. Corrigan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,700 13,700 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,700 13,700 - - Stock Option (Right to Buy)
Barbara Yanni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,700 13,700 - - Stock Option (Right to Buy)
Anne M. Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,700 13,700 - - Stock Option (Right to Buy)
Marvin H. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,700 13,700 - - Stock Option (Right to Buy)
Scott Braunstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 13,700 13,700 - - Stock Option (Right to Buy)
Yoder T. Robert SVP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.61 per share. 14 Dec 2023 92,500 135,806 (0%) 0% 0.6 56,425 Common Stock
T. Robert Yoder SVP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.61 per share. 14 Dec 2023 25,000 160,806 (0%) 0% 0.6 15,250 Common Stock
Robert T. Yoder SVP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.61 per share. 14 Dec 2023 1,929 158,877 (0%) 0% 0.6 1,177 Common Stock
Barry Shin SVP, CFO Grant, award, or other acquisition of securities at price $ 0.61 per share. 14 Dec 2023 50,000 312,437 (0%) 0% 0.6 30,500 Common Stock
M. Drake Patricia SVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.61 per share. 14 Dec 2023 1,835 107,078 (0%) 0% 0.6 1,119 Common Stock
Bourdow Carrie L. President & CEO Grant, award, or other acquisition of securities at price $ 0.61 per share. 14 Dec 2023 370,000 550,046 (0%) 0% 0.6 225,700 Common Stock
Shin Barry SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.61 per share. 14 Dec 2023 3,616 308,821 (0%) 0% 0.6 2,206 Common Stock
Carrie Bourdow L. President & CEO Grant, award, or other acquisition of securities at price $ 0.61 per share. 14 Dec 2023 100,000 650,046 (0%) 0% 0.6 61,000 Common Stock
Barry Shin SVP, CFO Grant, award, or other acquisition of securities at price $ 0.61 per share. 14 Dec 2023 185,000 262,437 (0%) 0% 0.6 112,850 Common Stock
Bourdow Carrie L. President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.61 per share. 14 Dec 2023 7,123 642,923 (0%) 0% 0.6 4,345 Common Stock
M. Drake Patricia SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.61 per share. 14 Dec 2023 50,000 83,913 (0%) 0% 0.6 30,500 Common Stock
Drake M. Patricia SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.61 per share. 14 Dec 2023 25,000 108,913 (0%) 0% 0.6 15,250 Common Stock
Mark Demitrack A. SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 497 79,531 (0%) 0% 0.6 293 Common Stock
Barry Shin SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 407 82,066 (0%) 0% 0.6 240 Common Stock
A. Mark Demitrack SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.61 per share. 02 Dec 2023 3,593 306,224 (0%) 0% 0.6 2,192 Common Stock
Barry Shin SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 1,023 81,043 (0%) 0% 0.6 604 Common Stock
A. Mark Demitrack SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 1,121 78,410 (0%) 0% 0.6 661 Common Stock
Patricia M. Drake SVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 1,835 33,913 (0%) 0% 0.6 1,083 Common Stock
Mark A. Demitrack SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.61 per share. 02 Dec 2023 185,000 259,817 (0%) 0% 0.6 112,850 Common Stock
Yoder T. Robert SVP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 436 45,976 (0%) 0% 0.6 257 Common Stock
Yoder T. Robert SVP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 741 45,235 (0%) 0% 0.6 437 Common Stock
Barry Shin SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 3,606 77,437 (0%) 0% 0.6 2,128 Common Stock
L. Carrie Bourdow President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 1,343 190,731 (0%) 0% 0.6 792 Common Stock
M. Patricia Drake SVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 294 35,748 (0%) 0% 0.6 173 Common Stock
Carrie L. Bourdow President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 3,562 187,169 (0%) 0% 0.6 2,102 Common Stock
T. Robert Yoder SVP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 1,929 43,306 (0%) 0% 0.6 1,138 Common Stock
Mark Demitrack A. SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 3,593 74,817 (0%) 0% 0.6 2,120 Common Stock
L. Bourdow Carrie President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. 02 Dec 2023 7,123 180,046 (0%) 0% 0.6 4,203 Common Stock
Mark Demitrack A. SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.61 per share. 02 Dec 2023 50,000 309,817 (0%) 0% 0.6 30,500 Common Stock
Mark H.N. Corrigan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jul 2023 34,250 34,250 - - Stock Option (Right to Buy)
Barry Shin SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.84 per share. 26 Jun 2023 722 82,545 (0%) 0% 0.8 606 Common Stock
Leon O. Moulder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 13,700 13,700 - - Stock Option (Right to Buy)
Michael R. Dougherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 13,700 13,700 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 13,700 13,700 - - Stock Option (Right to Buy)
Barbara Yanni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 13,700 13,700 - - Stock Option (Right to Buy)
Anne M. Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 13,700 13,700 - - Stock Option (Right to Buy)
Scott Braunstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 13,700 13,700 - - Stock Option (Right to Buy)
Marvin H. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 13,700 13,700 - - Stock Option (Right to Buy)
Carrie L. Bourdow Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 100,000 192,074 (0%) 0% 0 Common Stock
Mark A. Demitrack SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 50,000 80,028 (0%) 0% 0 Common Stock
Robert T. Yoder SVP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 25,000 46,412 (0%) 0% 0 Common Stock
Barry Shin SVP, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 50,000 83,267 (0%) 0% 0 Common Stock
Patricia M. Drake SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 25,000 36,674 (0%) 0% 0 Common Stock
Carrie L. Bourdow President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. 17 Dec 2022 1,342 92,074 (0%) 0% 1.5 2,080 Common Stock
Mark A. Demitrack SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. 17 Dec 2022 497 30,028 (0%) 0% 1.5 770 Common Stock
Robert T. Yoder SVP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. 17 Dec 2022 443 21,412 (0%) 0% 1.6 687 Common Stock
Barry Shin SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. 17 Dec 2022 413 33,267 (0%) 0% 1.5 640 Common Stock
Carrie L. Bourdow Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. 02 Dec 2022 3,560 93,416 (0%) 0% 3.4 12,175 Common Stock
Mark A. Demitrack SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. 02 Dec 2022 1,121 30,525 (0%) 0% 3.4 3,834 Common Stock
Robert T. Yoder SVP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. 02 Dec 2022 753 21,855 (0%) 0% 3.4 2,575 Common Stock
Barry Shin SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. 02 Dec 2022 1,170 33,680 (0%) 0% 3.4 4,001 Common Stock
Patricia M. Drake SVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. 02 Dec 2022 294 11,674 (0%) 0% 3.4 1,005 Common Stock
Patricia M. Drake SVP, Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.47 per share. 10 Nov 2022 632 11,968 (0%) 0% 2.5 1,561 Common Stock
Barry Shin SVP, CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.21 per share. 14 Sep 2022 1,792 871,264 (0%) 0% 0.2 369 Common Stock
Barry Shin SVP, CFO Sale of securities on an exchange or to another person at price $ 0.41 per share. 28 Jun 2022 31,785 873,056 (0%) 0% 0.4 13,032 Common Stock
Leon O. Moulder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Michael R. Dougherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Barbara Yanni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Anne M. Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Scott Braunstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Marvin Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 100,000 100,000 - - Stock Option (Right to Buy)
Carrie L. Bourdow Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 06 Dec 2021 93,561 2,457,949 (2%) 0% 0.7 60,815 Common Stock
Mark A. Demitrack SVP, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 06 Dec 2021 30,601 803,580 (0%) 0% 0.7 19,891 Common Stock
Robert T. Yoder SVP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 06 Dec 2021 22,950 574,916 (0%) 0% 0.7 14,918 Common Stock
Barry Shin SVP, CFO & CCO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 06 Dec 2021 34,408 919,057 (0%) 0% 0.6 22,365 Common Stock
Carrie L. Bourdow Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2021 1,250,000 2,551,510 (2%) 1% 0 Common Stock
Mark A. Demitrack SVP, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2021 390,000 834,181 (0%) 0% 0 Common Stock
Robert T. Yoder SVP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2021 240,000 597,866 (0%) 0% 0 Common Stock
Barry Shin SVP, CFO & CCO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2021 390,000 953,465 (1%) 0% 0 Common Stock
Barry Shin Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Sep 2021 27,500 563,465 (0%) 0% 0 Common Stock
Barry Shin Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Sep 2021 41,250 41,250 - - Stock Option (Right to Buy)
Carrie L. Bourdow Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.79 per share. 28 Jun 2021 56,200 1,301,510 (1%) 0% 1.8 100,542 Common Stock
Barry Shin Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.96 per share. 25 Jun 2021 24,635 535,965 (0%) 0% 2.0 48,285 Common Stock
Leon O. Moulder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 68,577 68,577 - - Stock Option (Right to Buy)
Michael R. Dougherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 68,577 68,577 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 68,577 68,577 - - Stock Option (Right to Buy)
Barbara Yanni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 68,577 68,577 - - Stock Option (Right to Buy)
Anne M. Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 68,577 68,577 - - Stock Option (Right to Buy)
Scott Braunstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 68,577 68,577 - - Stock Option (Right to Buy)
Marvin Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2021 118,880 118,880 - - Stock Option (Right to Buy)
Scott Applebaum CLCO; SVP, Regulatory Affairs Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. 10 Feb 2021 21,178 344,022 (0%) 0% 2.8 60,357 Common Stock
Scott Applebaum CLCO; SVP, Regulatory Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 172,750 172,750 - - Stock Option (Right to Buy)
Scott Applebaum CLCO; SVP, Regulatory Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 115,200 365,200 (0%) 0% 0 Common Stock
Carrie L. Bourdow Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 706,650 706,650 - - Stock Option (Right to Buy)
Carrie L. Bourdow Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 471,100 1,264,060 (1%) 0% 0 Common Stock
Mark A. Demitrack Sr. VP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 259,100 259,100 - - Stock Option (Right to Buy)
Mark A. Demitrack Sr. VP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 172,700 444,181 (0%) 0% 0 Common Stock
Robert T. Yoder SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 212,000 212,000 - - Stock Option (Right to Buy)
Robert T. Yoder SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 141,300 357,866 (0%) 0% 0 Common Stock
Barry Shin Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 235,550 235,550 - - Stock Option (Right to Buy)
Barry Shin Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2020 157,000 560,600 (0%) 0% 0 Common Stock
Carrie L. Bourdow Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. 07 Dec 2020 151,684 1,245,310 (1%) 0% 2.3 344,323 Common Stock
Mark A. Demitrack Sr. VP & Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. 07 Dec 2020 48,557 271,481 (0%) 0% 2.3 110,224 Common Stock
Robert T. Yoder Sr VP Chief Commercial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. 07 Dec 2020 36,688 216,566 (0%) 0% 2.3 83,282 Common Stock
Barry Shin Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. 07 Dec 2020 41,861 403,600 (0%) 0% 2.3 95,024 Common Stock
Robert T. Yoder Sr. VP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2020 59,000 59,000 - - Stock Option (Right to Buy)
Barry Shin Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.72 per share. 25 Jun 2020 23,539 445,461 (0%) 0% 1.7 40,487 Common Stock
Leon O. Moulder Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 64,103 64,103 - - Stock Option (Right to Buy)
Maxine Gowen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 64,103 64,103 - - Stock Option (Right to Buy)
Michael R. Dougherty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 64,103 64,103 - - Stock Option (Right to Buy)
Jake R. Nunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 64,103 64,103 - - Stock Option (Right to Buy)
Julie H. McHugh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 64,103 64,103 - - Stock Option (Right to Buy)
Barbara Yanni Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 64,103 64,103 - - Stock Option (Right to Buy)
Anne M. Phillips Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 64,103 64,103 - - Stock Option (Right to Buy)
Scott Braunstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2020 64,103 64,103 - - Stock Option (Right to Buy)
Scott Applebaum CLCO; SVP Regulatory Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 200,000 200,000 - - Stock Option (Right to Buy)
Scott Applebaum CLCO; SVP Regulatory Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2020 250,000 250,000 (0%) 0% 0 Common Stock
Carrie L. Bourdow Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 657,000 925,894 (0%) 0% 0 Common Stock
Mark A. Demitrack Sr. VP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 213,000 320,038 (0%) 0% 0 Common Stock
Robert T. Yoder Sr. VP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 167,000 253,254 (0%) 0% 0 Common Stock
Barry Shin Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2019 194,000 469,000 (0%) 0% 0 Common Stock
Carrie L. Bourdow Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. 02 Dec 2019 17,804 268,894 (0%) 0% 0.7 12,265 Common Stock
Mark A. Demitrack Sr. VP & Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. 02 Dec 2019 8,982 107,038 (0%) 0% 0.7 6,188 Common Stock
Robert T. Yoder Sr. VP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. 02 Dec 2019 6,874 86,254 (0%) 0% 0.7 4,735 Common Stock
Carrie L. Bourdow Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2019 250,000 250,000 - - Stock Option (Right to Buy)
Mark A. Demitrack Sr. VP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2019 50,000 50,000 - - Stock Option (Right to Buy)
Robert T. Yoder Sr. VP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Sep 2019 100,000 100,000 - - Stock Option (Right to Buy)
Barry Shin Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 275,000 275,000 (0%) 0% 0 Common Stock
Barry Shin Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 275,000 275,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.17 per share. 03 Jun 2019 17,802 286,698 (0%) 0% 1.2 20,828 Common Stock
Mark A. Demitrack Sr VP & Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.17 per share. 03 Jun 2019 8,980 116,020 (0%) 0% 1.2 10,507 Common Stock
Robert T. Yoder Sr. VP, Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.17 per share. 03 Jun 2019 6,872 93,128 (0%) 0% 1.2 8,040 Common Stock
John P. Hamill VP Fin,Princ Fin&Acct Officer Purchase of securities on an exchange or from another person at price $ 1.16 per share. 31 May 2019 7,500 87,750 (0%) 0% 1.2 8,700 Common Stock
John P. Hamill VP Fin,Princ Fin&Acct Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.17 per share. 31 May 2019 5,516 82,234 (0%) 0% 1.2 6,454 Common Stock
Leon O. Moulder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2019 30,000 30,000 - - Stock Option (Right to Buy)
Maxine Gowen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2019 30,000 30,000 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2019 30,000 30,000 - - Stock Option (Right to Buy)
Jake R. Nunn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2019 30,000 30,000 - - Stock Option (Right to Buy)
Julie H. McHugh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2019 30,000 30,000 - - Stock Option (Right to Buy)
Barbara Yanni None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2019 30,000 30,000 - - Stock Option (Right to Buy)
Anne M. Phillips None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2019 30,000 30,000 - - Stock Option (Right to Buy)
Scott Braunstein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2019 30,000 30,000 - - Stock Option (Right to Buy)
Leon O. Moulder None Purchase of securities on an exchange or from another person at price $ 1.02 per share. 01 Feb 2019 100,000 100,000 (0%) 0% 1.0 102,000 Common Stock
Maxine Gowen Director, President & CEO Purchase of securities on an exchange or from another person at price $ 1.02 per share. 01 Feb 2019 50,000 54,000 (0%) 0% 1.0 51,000 Common Stock
Carrie L. Bourdow Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.02 per share. 01 Feb 2019 50,000 304,500 (0%) 0% 1.0 51,000 Common Stock
John P. Hamill VP Fin,Princ Fin&Acct Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2018 80,000 80,250 (0%) 0% 0 Common Stock
Carrie L. Bourdow Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2018 250,000 250,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2018 250,000 254,500 (0%) 0% 0 Common Stock
Mark A. Demitrack Sr VP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2018 125,000 125,000 - - Stock Option (Right to Buy)
Mark A. Demitrack Sr VP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2018 125,000 125,000 (0%) 0% 0 Common Stock
Robert T. Yoder Sr. VP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2018 100,000 100,000 (0%) 0% 0 Common Stock
Robert T. Yoder Sr. VP, Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Dec 2018 100,000 100,000 - - Stock Option (Right to Buy)
Carrie L. Bourdow Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Sep 2018 335,000 335,000 - - Employee Stock Option (Right to Buy)
Scott Braunstein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Sep 2018 60,000 60,000 - - Stock Option (Right to Buy)
John P. Hamill VP Fin,Princ Fin&Acct Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2018 52,500 52,500 - - Stock Option (Right to Buy)
Mark A. Demitrack Sr VP & Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2018 200,000 200,000 - - Stock Option (Right to Buy)
Leon O. Moulder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2018 30,000 30,000 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2018 30,000 30,000 - - Stock Option (Right to Buy)
Jake R. Nunn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2018 30,000 30,000 - - Stock Option (Right to Buy)
Julie H. McHugh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2018 30,000 30,000 - - Stock Option (Right to Buy)
Adam Koppel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2018 30,000 30,000 - - Stock Option (Right to Buy)
Barbara Yanni None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2018 30,000 30,000 - - Stock Option (Right to Buy)
Anne M. Phillips None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2018 30,000 30,000 - - Stock Option (Right to Buy)
Yacoub Habib SVP, Bus Dev & Corp Planning Sale of securities on an exchange or to another person at price $ 1.76 per share. 22 Mar 2018 5,000 0 (0%) 0% 1.8 8,800 Common Stock
John M. Limongelli Sr. VP,General Counsel & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 44,000 44,000 - - Employee Stock Option (Right to Buy)
John M. Limongelli Sr. VP,General Counsel & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 65,000 65,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 252,500 252,500 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 150,000 150,000 - - Employee Stock Option (Right to Buy)
Roberto Cuca Sr. VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 44,000 44,000 - - Employee Stock Option (Right to Buy)
Roberto Cuca Sr. VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 65,000 65,000 - - Employee Stock Option (Right to Buy)
Jonathan Violin SVP-Scientific Affairs & IR Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 75,000 75,000 - - Employee Stock Option (Right to Buy)
Jonathan Violin SVP-Scientific Affairs & IR Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 65,000 65,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow EVP & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 124,000 124,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow EVP & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 112,500 112,500 - - Employee Stock Option (Right to Buy)
Yacoub Habib SVP, Bus Dev & Corp Planning Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 44,000 44,000 - - Employee Stock Option (Right to Buy)
Yacoub Habib SVP, Bus Dev & Corp Planning Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 65,000 65,000 - - Employee Stock Option (Right to Buy)
David Geoghegan Sr. VP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 75,000 75,000 - - Employee Stock Option (Right to Buy)
David Geoghegan Sr. VP, Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2018 65,000 65,000 - - Employee Stock Option (Right to Buy)
John M. Limongelli Sr. VP,General Counsel & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2017 66,000 66,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2017 225,000 225,000 - - Employee Stock Option (Right to Buy)
Michael W. Lark Sr. VP, Research & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2017 66,000 66,000 - - Employee Stock Option (Right to Buy)
Roberto Cuca Sr. VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2017 66,000 66,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2017 66,000 66,000 - - Employee Stock Option (Right to Buy)
Yacoub Habib SVP, Bus Dev & Corp Planning Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2017 66,000 66,000 - - Employee Stock Option (Right to Buy)
Leon O. Moulder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 15,000 15,000 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 15,000 15,000 - - Stock Option (Right to Buy)
Jake R. Nunn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 15,000 15,000 - - Stock Option (Right to Buy)
Julie H. McHugh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 15,000 15,000 - - Stock Option (Right to Buy)
Adam Koppel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 15,000 15,000 - - Stock Option (Right to Buy)
Barbara Yanni None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 15,000 15,000 - - Stock Option (Right to Buy)
Anne M. Phillips None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2017 15,000 15,000 - - Stock Option (Right to Buy)
John M. Limongelli Sr. VP,General Counsel & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2017 91,000 91,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2017 303,000 303,000 - - Employee Stock Option (Right to Buy)
Michael W. Lark Sr. VP, Research & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2017 91,000 91,000 - - Employee Stock Option (Right to Buy)
Roberto Cuca Sr. VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2017 113,750 113,750 - - Employee Stock Option (Right to Buy)
David Soergel Sr. VP,Clinical Dev. & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2017 91,000 91,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2017 91,000 91,000 - - Employee Stock Option (Right to Buy)
Yacoub Habib SVP, Bus Dev & Corp Planning Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2017 91,000 91,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. 23 Feb 2017 110,403 126,903 (0%) 0% 0.7 75,295 Common Stock
Maxine Gowen Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2017 106,329 0 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Feb 2017 4,074 0 - - Employee Stock Option (Right to Buy)
Michael W. Lark Sr. VP, Research & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. 10 Feb 2017 12,815 98,460 (0%) 0% 0.7 8,740 Common Stock
Michael W. Lark Sr. VP, Research & CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2017 12,815 48,362 - - Employee Stock Option (Right to Buy)
Michael W. Lark Sr. VP, Research & CSO Sale of securities on an exchange or to another person at price $ 8.00 per share. 10 Feb 2017 23,699 74,761 (0%) 0% 8 189,592 Common Stock
John M. Limongelli Sr. VP,General Counsel & CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 55,000 55,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 403 195,512 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 175,000 175,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 50,000 64,403 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 50,000 195,109 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 60,000 4,403 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 60,000 216,500 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 403 4,000 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 150,000 4,000 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 150,000 150,000 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 6,500 120,403 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 6,500 156,500 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 6,000 114,403 (0%) 0% 0 Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 06 Jan 2017 6,000 145,109 (0%) 0% 0 Common Stock
Michael W. Lark Sr. VP, Research & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 55,000 55,000 - - Employee Stock Option (Right to Buy)
Roberto Cuca Sr. VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 55,000 55,000 - - Employee Stock Option (Right to Buy)
David Soergel Sr. VP,Clinical Dev. & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 55,000 55,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 55,000 55,000 - - Employee Stock Option (Right to Buy)
Yacoub Habib SVP, Bus Dev & Corp Planning Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2017 55,000 55,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow SVP, Chief Commercial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Nov 2016 4,000 4,500 - - Common Stock
Maxine Gowen Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Nov 2016 12,500 16,500 - - Common Stock
Yacoub Habib SVP, Bus Dev & Corp Planning Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Nov 2016 5,000 5,000 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 20 Oct 2016 4,084 4,000 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 20 Oct 2016 4,084 139,109 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 20 Oct 2016 10,000 154,000 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 20 Oct 2016 10,000 8,084 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 29 Sep 2016 130,000 134,000 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 29 Sep 2016 10,000 144,000 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 29 Sep 2016 10,000 18,084 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 29 Sep 2016 135,025 135,025 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 29 Sep 2016 130,000 163,109 - - Common Stock
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 29 Sep 2016 135,025 28,084 - - Common Stock
Maxine Gowen Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 May 2016 4,000 4,000 - - Common Stock
Maxine Gowen Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 May 2016 4,000 279,025 - - Common Stock
Maxine Gowen Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 May 2016 14,084 293,109 - - Common Stock
Leon O. Moulder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2016 15,000 15,000 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2016 15,000 15,000 - - Stock Option (Right to Buy)
Jake R. Nunn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2016 15,000 15,000 - - Director Stock Option (Right to Buy)
Julie H. McHugh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2016 15,000 15,000 - - Stock Option (Right to Buy)
Adam Koppel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2016 15,000 15,000 - - Stock Option (Right to Buy)
Barbara Yanni None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2016 15,000 15,000 - - Stock Option (Right to Buy)
Anne M. Phillips None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2016 15,000 15,000 - - Stock Option (Right to Buy)
John M. Limongelli Sr. VP,General Counsel & Secy Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2016 118,750 118,750 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2016 350,000 350,000 - - Employee Stock Option (Right to Buy)
Michael W. Lark Sr. VP, Research & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2016 118,750 118,750 - - Employee Stock Option (Right to Buy)
Roberto Cuca Sr. VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2016 95,000 95,000 - - Employee Stock Option (Right to Buy)
David Soergel Sr. VP,Clinical Dev. & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2016 105,000 105,000 - - Employee Stock Option (Right to Buy)
Carrie L. Bourdow SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2016 95,000 95,000 - - Employee Stock Option (Right to Buy)
Yacoub Habib SVP, Bus Dev & Corp Planning Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2016 95,000 95,000 - - Employee Stock Option (Right to Buy)
David Soergel Sr. VP,Clinical Dev. & CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Dec 2015 27,217 1,750 - - Common Stock
Jake R. Nunn None Other type of transaction at price $ 0.00 per share. 09 Dec 2015 4,271 4,271 - - Common Stock
Yacoub Habib SVP, Bus Dev & Corp Planning Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2015 125,000 125,000 - - Employee Stock Option (Right to Buy)
Francois Nader None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2015 8,870 8,870 - - Stock Option (Right to Buy)
Leon O. Moulder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2015 8,870 8,870 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2015 8,870 8,870 - - Stock Option (Right to Buy)
Jake R. Nunn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2015 8,870 8,870 - - Director Stock Option (Right to Buy)
Julie H. McHugh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2015 8,870 8,870 - - Stock Option (Right to Buy)
Adam Koppel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2015 8,870 8,870 - - Stock Option (Right to Buy)
Barbara Yanni None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2015 8,870 8,870 - - Stock Option (Right to Buy)
Anne M. Phillips None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2015 8,870 8,870 - - Stock Option (Right to Buy)
Carrie L. Bourdow SVP, Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2015 125,000 125,000 - - Employee Stock Option (Right to Buy)
John M. Limongelli Sr. VP,General Counsel & Secy Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2015 70,000 70,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2015 300,000 300,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Gift of securities by or to the insider at price $ 0.00 per share. 17 Mar 2015 51,000 275,025 - - Common Stock
Michael W. Lark Sr. VP, Research & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2015 87,500 87,500 - - Employee Stock Option (Right to Buy)
Roberto Cuca Sr. VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2015 70,000 70,000 - - Employee Stock Option (Right to Buy)
David Soergel Sr. VP,Clinical Dev. & CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2015 87,500 87,500 - - Employee Stock Option (Right to Buy)
Anne M. Phillips None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2014 17,741 17,741 - - Stock Option (Right to Buy)
John M. Limongelli Sr. VP,General Counsel & Secy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Dec 2014 3,000 12,000 - - Common Stock
John M. Limongelli Sr. VP,General Counsel & Secy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Dec 2014 9,000 9,000 - - Common Stock
Maxine Gowen Director, President & CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Dec 2014 8,000 326,025 - - Common Stock
Michael R. Dougherty None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Dec 2014 7,000 7,000 - - Common Stock
Michael W. Lark Sr. VP, Research & CSO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Dec 2014 5,000 85,645 - - Common Stock
Roberto Cuca Sr. VP and CFO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Dec 2014 25,000 25,000 - - Common Stock
Barbara Yanni None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Dec 2014 1,250 1,250 - - Common Stock
Leon O. Moulder None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Dec 2014 30,200 30,200 - - Common Stock
Leon O. Moulder None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Dec 2014 19,800 50,000 - - Common Stock
David Soergel Sr. VP, Clinical Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Dec 2014 500 27,717 - - Common Stock
David Soergel Sr. VP, Clinical Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Dec 2014 1,250 28,967 - - Common Stock
Rosamond Deegan Sr VP, Bus Dev & Operations Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Sep 2014 44 31,105 - - Common Stock
Adam Koppel None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Sep 2014 17,741 17,741 - - Stock Option (Right to Buy)
Julie H. McHugh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2014 17,741 17,741 - - Stock Option (Right to Buy)
Barbara Yanni None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2014 17,741 17,741 - - Stock Option (Right to Buy)
Francois Nader None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2014 8,870 8,870 - - Stock Option (Right to Buy)
Howard Solomon None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2014 8,870 8,870 - - Stock Option (Right to Buy)
John M. Limongelli Sr. VP,General Counsel & Secy Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2014 100,000 100,000 - - Employee Stock Option (Right to Buy)
Leon O. Moulder None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2014 8,870 8,870 - - Stock Option (Right to Buy)
Terrance G. Mcguire Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2014 8,870 8,870 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2014 8,870 8,870 - - Stock Option (Right to Buy)
Jake R. Nunn None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2014 8,870 8,870 - - Director Stock Option (Right to Buy)
Farah Champsi Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2014 8,870 8,870 - - Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Apr 2014 124,477 318,025 - - Common Stock
Maxine Gowen Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Apr 2014 124,477 106,329 - - Employee Stock Option (Right to Buy)
Robert Prachar Sr. VP, Corp. Strategy Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2014 100,000 100,000 - - Employee Stock Option (Right to Buy)
Maxine Gowen Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2014 175,000 175,000 - - Employee Stock Option (Right to Buy)
Michael W. Lark Sr. VP, Research & CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2014 50,000 50,000 - - Employee Stock Option (Right to Buy)
Roberto Cuca Sr. VP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2014 50,000 50,000 - - Employee Stock Option (Right to Buy)
David Soergel Sr. VP, Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2014 55,000 55,000 - - Employee Stock Option (Right to Buy)
Rosamond Deegan Sr VP, Bus Dev & Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2014 60,000 60,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters